RANI THERAPEUTICS HOLDINGS, INC. Cash and Restricted Cash
RANI THERAPEUTICS HOLDINGS, INC. (RANI) had Cash and Restricted Cash of $5.07 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.07M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.84M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.82M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.64M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $5.07M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $9.84M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $18.82M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.64M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $10.72M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $10.61M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $4.26M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $4.78M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $5.01M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $7.38M 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $6.36M 10-K · filed 2026-03-26 | |
| 2023-09-30 | $5.47M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $8.05M 10-Q · filed 2024-08-06 | |
| 2023-03-31 | $19.48M 10-Q · filed 2024-05-06 | |
| 2022-12-31 | $27.51M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $27.72M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $97.18M 10-Q · filed 2023-08-11 | $97.20M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $107.84M 10-Q · filed 2023-05-10 | $107.80M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $117.45M 10-K · filed 2024-03-20 | $117.50M 10-K · filed 2022-03-31 |
| 2021-09-30 | $129.74M 10-Q · filed 2022-11-10 | $129.70M 10-Q · filed 2021-11-16 |
| 2021-06-30 | $69.30M 10-Q · filed 2021-09-13 | |
| 2020-12-31 | $73.06M 10-K · filed 2023-03-22 |